Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
New combo therapy shows promise for advanced kidney cancer
Disease control OngoingThis study tests whether adding a supplement called Seleno-L methionine to the standard two-drug therapy (axitinib and pembrolizumab) is safe and works better for people with advanced clear cell kidney cancer. About 55 participants will receive the combination. The goal is to see…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could a common bone drug help fight a rare cancer?
Disease control OngoingThis early-phase trial tests whether zoledronic acid, a drug usually used for bone thinning, can help shrink or control chondrosarcoma tumors before surgery. About 17 adults with this rare bone cancer will receive the drug and then have their tumors removed. The main goals are to…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 14, 2026 12:06 UTC